Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria
Clinical trial NCT02619929 · COMPLETED
Trial details
- NCT number
- NCT02619929
- Sponsor
- Pierre Fabre Pharma GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-03-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.